You are here

  • Home
  • Archive
  • Volume 5, Issue 4
  • Review: ipratropium bromide with β-agonists improves pulmonary function and reduces admissions to hospital in acute asthma

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: ipratropium bromide with β-agonists improves pulmonary function and reduces admissions to hospital in acute asthma

https://doi.org/10.1136/ebm.5.4.107

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (1999) Am J Med 107, 363. Rodrigo G, Rodrigo C, Burschtin O.. A meta-analysis of the effects of ipratropium bromide in adults with acute asthma.. Oct;. :. –70.
    OpenUrlCrossRefPubMedWeb of Science

    
 
 QUESTION: In adults with acute asthma treated with β-agonists, does the addition of ipratropium bromide improve pulmonary function during the first 90 minutes of treatment and reduce the rate of admissions to hospital?

    Data sources

    Studies were identified by searching Medline (1978 to April 1999), Current Contents, Science Citation Index, review articles, bibliographies of relevant articles, and the register of the Medical Editors' Trial Amnesty and by contacting experts and the manufacturer of ipratropium.

    Study selection

    English language studies were selected if they were randomised, doubled blind, controlled trials (RCTs); patients (>16 y of age) had acute asthma and were treated in an emergency department with β-agonists; pulmonary function was measured as a continuous variable; and sufficient data were available to calculate effect sizes.

    Data extraction

    Data were extracted on year and source of publication, country, number of patients, patient characteristics, dose and route of all medications, spirometric measures used, mean …

    View Full Text

    Footnotes

    • Source of funding: no external funding.

    • For correspondence: Dr C Rodrigo, Centro de Terapia Intensiva, Asociación Española 1a de Socorros Mutuos, Bulevar Artigas 1465, Montevideo 11300, Uruguay.